Cargando…
CT-guided (125)I brachytherapy for recurrent ovarian cancer
This retrospective study was to evaluate the local control and survival of (125)I brachytherapy for recurrent ovarian cancer. 52 (125)I brachytherapy procedures were performed in 47 patients with 51 recurrent ovarian cancer lesions. The follow-up period was 1-55 months (median 12 months). The local...
Autores principales: | Liu, Ping, Tong, Lina, Huo, Bin, Dai, Dong, Liu, Wenxin, Wang, Ke, Wang, Ying, Guo, Zhi, Ni, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601776/ https://www.ncbi.nlm.nih.gov/pubmed/28938680 http://dx.doi.org/10.18632/oncotarget.15905 |
Ejemplares similares
-
CT-guided (125)I interstitial brachytherapy for pelvic recurrent cervical carcinoma after radiotherapy
por: Tong, Lina, et al.
Publicado: (2017) -
CT-guided (125)I brachytherapy for locally recurrent nasopharyngeal carcinoma
por: Yan, Huzheng, et al.
Publicado: (2017) -
CT-guided iodine-125 brachytherapy as salvage therapy for local-regional recurrent breast cancer
por: Wang, Juan, et al.
Publicado: (2023) -
Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer
por: Jiang, Qin, et al.
Publicado: (2021) -
Efficacy and safety of CT-guided (125)I brachytherapy in elderly patients with non-small cell lung cancer
por: Zhao, Jing, et al.
Publicado: (2020)